ALK-Abelló A/S
ALK-B
Kedudukan dalam Saham
#2433
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Harga Saham
$36.23
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$8.04B
Perubahan (1 hari)
-1.72%
Perubahan (1 tahun)
12.00%
Negara
DK
Perdagangan ALK-Abelló A/S (ALK-B)
Kategori
Healthcare
Modal pasaran bagi ALK-Abelló A/S(ALK-B)
Modal Pasaran: $8.04B
Sehingga October 2026, ALK-Abelló A/S mempunyai modal pasaran sebanyak $8.04B. Ini menjadikan ALK-Abelló A/S syarikat ke-2433rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran ALK-Abelló A/S dari 2009 hingga 2026
ALK-B berbanding dengan 5 teratas yang paling popular stocks
